Danaher’s stock drop looks like a buying opportunity after it reported a solid quarter

Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.

Estee Lauder’s latest Wall Street endorsement underscores our long-held view on the companyMicrosoft’s post-earnings stock moves reinforce a key Club investing rule Jim Cramer’s Investing Club meeting Wednesday: Microsoft, PG, Estee Lauder